Ignite Creation Date:
2024-05-06 @ 4:10 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04899726
Status:
UNKNOWN
Last Update Posted:
2021-05-26
First Post:
2021-05-21
Brief Title:
Description of the Safety and Functionality of a Rectoscope P201630551
Sponsor:
Instituto de Investigación Hospital Universitario La Paz
Organization:
Instituto de Investigación Hospital Universitario La Paz
Study Overview
Official Title:
Description of the Safety and Functionality of a Rectoscope P201630551 That Allows the Identification of the Distal Section Margin in Oncological Rectal Surgery
Status:
UNKNOWN
Status Verified Date:
2021-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Most patients with rectal cancer receive neoadjuvant therapy This usually causes a decrease in tumor size In approximately 20 of patients who receive neoadjuvant therapy the tumor disappears completely complete pathological response showing as a scar on the rectal mucosa not noticeable from the rectal serosa from outside the rectum difficulting the identification of the tumor location by the surgeon
Rectoscope p201630551 allows the surgeon to view the illuminated rectum from the patients abdomen determining the appropriate point of section of the rectum
Rectoscope p201630551 allows the surgeon to view the illuminated rectum from the patients abdomen determining the appropriate point of section of the rectum
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None